Is chronic hepatitis B being undertreated in the U.S.?
C. A. Cohen, MPH1, Scott D. Holmberg, MD, MPH2, Brian J. McMahon, MD3, Joan Block, RN, BSN1, Carol L. Brosgart, MD4, Robert G. Gish, MD5, W.T. London, MD1 and T. Block, PhD6
(1)Hepatitis B Foundation, Doylestown, PA, (2)Centers for Disease Control and Prevention, Atlanta, GA, (3)Alaska Native Tribal Health Consortium, Anchorage, AK, (4)Alios Biopharma, Inc., San Francisco, CA, (5)UCSD, San Diego, CA, (6)Drexel University, Philadelphia, PA
(1)Hepatitis B Foundation, Doylestown, PA, (2)Centers for Disease Control and Prevention, Atlanta, GA, (3)Alaska Native Tribal Health Consortium, Anchorage, AK, (4)Alios Biopharma, Inc., San Francisco, CA, (5)UCSD, San Diego, CA, (6)Drexel University, Philadelphia, PA